EDX Medical Group Plc (AIM:EDX)

Market Cap	27.78M -37.8%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	411.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	144,740
Open	7.40
Previous Close	6.75
Day's Range	7.40 - 7.50
52-Week Range	6.00 - 13.25
Beta	1.37
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About EDX Medical Group

EDX Medical Group Plc, together with its subsidiaries, provides diagnostic products and solutions in the United Kingdom. It operates in two segments, Medical Goods and Medical Services. The company offers Caris MI Profile, a tumour profiling platform; cResponse, a platform the assess and predicts the effectiveness of single and multi drug chemotherapy; MI Tumor Seek, a next generation sequencing based tumour profiling service; Caris Assure, a blood based comprehensive molecular profiling designed for patients with previously diagnosed solid tum...

• Industry: Medical Laboratories
• Founded: 2021
• Country: United Kingdom
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EDX

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 6, 2026

Data Sources Report a data error